Table 3 Performance of the 90-gene expression assay in clinicopathological subsets
Clinical variables | Number | Agreement | Accuracy (%) |
|---|---|---|---|
Study | Â | Â | Â |
 Retrospective | 924 | 884 | 95.7 |
 Prospective | 493 | 454 | 92.1 |
Histologic grade | Â | Â | Â |
 Well-moderately differentiated | 418 | 399 | 95.5 |
 Poorly differentiated/Undifferentiated | 694 | 656 | 94.5 |
Histological type | Â | Â | Â |
 Adenocarcinoma | 943 | 898 | 95.2 |
 Squamous cell carcinoma | 166 | 151 | 91.0 |
 Urothelial carcinoma | 55 | 53 | 95.4 |
 Melanoma | 54 | 48 | 88.9 |
 Neuroendocrine tumor | 52 | 49 | 94.2 |
 Tumor | 49 | 45 | 91.8 |
  Sarcoma | 46 | 43 | 93.5 |
  Germ cell tumor | 40 | 39 | 97.5 |
  Mesothelioma | 12 | 12 | 100 |
Institution | Â | Â | Â |
 BCH | 518 | 489 | 94.4 |
 FUSCC | 424 | 403 | 95.0 |
 ZCH | 475 | 446 | 93.9 |